Advertisement
ANIX vs CRSP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and CRSP is a Hold.
ANIX sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for ANIX moved below the 200-day moving average on November 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for ANIX moved out of overbought territory on October 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 21 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 53 cases where ANIX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
ANIX broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on ANIX as a result. In 79 of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for ANIX just turned positive on October 22, 2026. Looking at past instances where ANIX's MACD turned positive, the stock continued to rise in 39 of 47 cases over the following month. The odds of a continued upward trend are 83%.
ANIX moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ANIX crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Following a +9.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIX advanced for three days, in 180 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. ANIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.627) is normal, around the industry mean (3.498). P/E Ratio (-9.922) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (384.615) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
CRSP in downward trend: 10-day moving average broke below 50-day moving average on October 08, 2026
The 10-day moving average for CRSP crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
CRSP moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRSP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
CRSP broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CRSP entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on CRSP as a result. In 80 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for CRSP just turned positive on October 28, 2026. Looking at past instances where CRSP's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.
Following a +5.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRSP advanced for three days, in 210 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.772) is normal, around the industry mean (3.498). P/E Ratio (-10.631) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (454.545) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. CRSP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
ANIX | CRSP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 23 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 24 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 96 | |
PRICE GROWTH RATING 1..100 | 55 | 69 | |
P/E GROWTH RATING 1..100 | 29 | 55 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CRSP's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for ANIX (68) in the Computer Peripherals industry. This means that CRSP’s stock grew somewhat faster than ANIX’s over the last 12 months.
CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that CRSP’s stock grew similarly to ANIX’s over the last 12 months.
CRSP's SMR Rating (96) in the Biotechnology industry is in the same range as ANIX (98) in the Computer Peripherals industry. This means that CRSP’s stock grew similarly to ANIX’s over the last 12 months.
ANIX's Price Growth Rating (55) in the Computer Peripherals industry is in the same range as CRSP (69) in the Biotechnology industry. This means that ANIX’s stock grew similarly to CRSP’s over the last 12 months.
ANIX's P/E Growth Rating (29) in the Computer Peripherals industry is in the same range as CRSP (55) in the Biotechnology industry. This means that ANIX’s stock grew similarly to CRSP’s over the last 12 months.
| ANIX | CRSP | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 78% | N/A |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 83% |
| Momentum ODDS (%) | 1 day ago 77% | 1 day ago 82% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 79% | 1 day ago 80% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 80% |
| Advances ODDS (%) | 6 days ago 81% | 12 days ago 82% |
| Declines ODDS (%) | 8 days ago 82% | 8 days ago 81% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 83% |
| Aroon ODDS (%) | N/A | 1 day ago 82% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANIX’s FA Score shows that 1 FA rating(s) are green while CRSP’s FA Score has 1 green FA rating(s).
- ANIX’s FA Score: 1 green, 4 red.
- CRSP’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANIX’s TA Score shows that 5 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).
- ANIX’s TA Score: 5 bullish, 5 bearish.
- CRSP’s TA Score: 4 bullish, 5 bearish.
Price Growth
ANIX (@Biotechnology) experienced а +1.76% price change this week, while CRSP (@Biotechnology) price change was -2.63% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.97%. For the same industry, the average monthly price growth was -8.33%, and the average quarterly price growth was +85.08%.
Reported Earning Dates
ANIX is expected to report earnings on Jan 06, 2027.
CRSP is expected to report earnings on Feb 16, 2027.
Industries' Descriptions
@Biotechnology (+2.97% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ANIX and
Correlation & Price change
A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with PRME. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then PRME could also see price increases.
| Ticker / NAME | Correlation To ANIX | 1D Price Change % | ||
|---|---|---|---|---|
| ANIX | 100% | -0.47% | ||
| PRME - ANIX | 45% Loosely correlated | -7.53% | ||
| TNYA - ANIX | 42% Loosely correlated | +9.38% | ||
| RXRX - ANIX | 42% Loosely correlated | +8.10% | ||
| RCKT - ANIX | 41% Loosely correlated | +6.08% | ||
| CRSP - ANIX | 40% Loosely correlated | -0.06% | ||
More | ||||
CRSP and
Correlation & Price change
A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.
| Ticker / NAME | Correlation To CRSP | 1D Price Change % | ||
|---|---|---|---|---|
| CRSP | 100% | -0.06% | ||
| BEAM - CRSP | 77% Closely correlated | +2.31% | ||
| NTLA - CRSP | 71% Closely correlated | +6.70% | ||
| PRME - CRSP | 65% Loosely correlated | -7.53% | ||
| RXRX - CRSP | 65% Loosely correlated | +8.10% | ||
| EDIT - CRSP | 63% Loosely correlated | +7.00% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TSCM | 18.64 | 0.79 | +4.45% |
| TimesSquare Quality Mid Cap Growth ETF (TSCM) | |||
| DGRE | 36.98 | 1.08 | +3.00% |
| WisdomTree Emerging Markets Quality Dividend Growth Fund (DGRE) | |||
| AOA | 96.51 | 1.95 | +2.06% |
| iShares Core 80/20 Aggressive Allocation ETF (AOA) | |||
| GJUN | 41.79 | 0.58 | +1.40% |
| FT Vest U.S. Equity Moderate Buffer ETF - June (GJUN) | |||
| DWSH | 5.27 | -0.09 | -1.59% |
| AdvisorShares Dorsey Wright Short ETF (DWSH) | |||